News & Views
Aquatreck signs research agreement with Biodetect
December 20, 2022 By Hatchery International staff
Aquatreck Animal Health S.L, a fish vaccine company established in 2019 in Pontevedra, Spain, signed an exclusive research agreement with Biodetect, a diagnostic lab based at the University of Patras, with the aim to launch a series on novel diagnostic services for the aquaculture sector focusing on pathogen epidemiological mapping in the fish farm environment.
“We are delighted to grow AQUATRECK capacity through research alliances and we are convinced that with the addition of the BioDetect team, we will be able to provide the industry with novel insights into the epidemiology of fish pathogens and health monitoring,” said Panos Christofilogiannis, director of Aquatreck.
According to the companies, the research collaboration aims to make the epidemiological mapping of fish diseases more efficient by using novel diagnostic tools to increase the predictability of the onset of fish diseases and the improved planning of the farm vaccination plans. In addition, it will provide an early warning system to identify emerging pathogens in the farm environment and mobilise specific research on new vaccine production for pathogen containment strategies.
“We have developed novel methods for monitoring fish pathogens in the farm environment and we are excited to have Aquatreck as our strategic ally to fast track the process to bring novel diagnostic services to the aquaculture industry,” said George Tsiamis, director of BioDetect.
Print this page
- Nofima researchers developed new genomic tool for cod
- Russian largest aquaculture producer seeks to acquire a new hatchery